CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00621543
NCT00621543N/ACompleted
CompareCT.gov

Insertion of an IUD After Medical Abortion

Boston University·interventional·Posted Feb 22, 2008·Updated Jul 14, 2011

In Brief

A clinical study evaluating IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS] for Intrauterine Device Expulsion and 2 related conditions. Completed, enrolled 120 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine the expulsion and continuation rate of an intruterine device (IUD) placed immediately after medical abortion. Our hypothesis is that immediate-placement of an IUD after completed medical abortion will have a similar expulsion and continuation rate to traditional placement (4-6 weeks after pregnancy).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntrauterine Device Expulsion, Medical Abortion, Induced Abortion
CountriesUnited States
CollaboratorsUniversity of Utah

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 22, 2008
Enrollment StartMar 1, 2006
Primary CompletionMay 1, 2008
Study CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 18.4 years ago

Interventions

IUD insertion [Copper T-380A or Levonorgestrel (intrauterine system) IUS]device

When a subject has chosen a method of intra-uterine contraception and has agreed to participate in the study, she will have the intra-uterine device of her choice inserted according to the Food and Druga Administration (FDA) instructions.